RecruitingPhase 4NCT07095361
Once Daily Intrapleural Enzyme Therapy in Complicated Parapneumonic Effusion or Empyema
Studying Pleural empyema
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University of North Carolina, Chapel Hill
- Principal Investigator
- Jason Akulian, MD, MPHUniversity of North Carollina at Chapel Hill
- Intervention
- Fibrinolytic once daily(drug)
- Enrollment
- 270 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2025 – 2027
Study locations (1)
- UNC Chapel Hill, Chapel Hill, North Carolina, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT07095361 on ClinicalTrials.govOther trials for Pleural empyema
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT07337993Fungal Empyema ThoracisUniversity of Health Sciences Lahore
- RECRUITINGNANCT06434324Pleural Space Saline Irrigation in Addition to Standard Intrapleural Thrombolytic Therapy in Empyema/Complicated Parapneumonic EffusionMayo Clinic
- RECRUITINGNANCT06427538Chest Drain Regular Flushing in Complicated Parapneumonic Effusions and EmpyemasVanderbilt University Medical Center
- RECRUITINGNCT06657898Complicated Pneumonia (CP) in Children in South-East EuropeAleksandar Sovtic
- RECRUITINGNANCT06787885Evaluation of Efficacy and Safety Parameters of Different Antibiotics Regimens for Management of EmpyemaFayoum University
- RECRUITINGNANCT06734481Effectiveness and Safety of Sodium Bicarbonate Pleural Lavage in the Treatment of Complex Pleural EffusionFirst Affiliated Hospital of Ningbo University
- RECRUITINGNANCT06424457Pediatric Video Assisted Thoracoscopic Surgery (VATS) in Management of EmpyemaAssiut University
- RECRUITINGNANCT04095676VATS Surgery Compared to Drainage in the Treatment of Pleural EmpyemaThomas Decker Christensen